UNICREDIT BANK/CALL/INTUITIVE SURGICAL/300/0.1/19.06.24 Share Price

Warrant

DE000HC3L654

Market Closed - BOERSE MUENCHEN 01:10:43 01/06/2024 am IST
9.19 EUR -3.47% Intraday chart for UNICREDIT BANK/CALL/INTUITIVE SURGICAL/300/0.1/19.06.24
1 month+31.47%
3 months+4.31%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
31/24/31 9.19 -3.47%
30/24/30 9.52 +3.70%
29/24/29 9.18 -1.40%
28/24/28 9.31 -5.96%
27/24/27 9.9 +1.33%

Real-time BOERSE MUENCHEN

Last update May 01, 2024 at 01:10 am IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying INTUITIVE SURGICAL, INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HC3L65
ISINDE000HC3L654
Date issued 27/01/2023
Strike 300 $
Maturity 19/06/2024 (18 Days)
Parity 10 : 1
Emission price 3
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 10.12
Lowest since issue 1.64
Delta0x
Omega 0.000000
Premium0x
Gearing0x
Moneyness 1.340
Difference Strike -102.1 $
Difference Strike %-34.04%
Intrinsic value 9.414

Company Profile

Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Sector
-
More about the company

Ratings for Intuitive Surgical, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Intuitive Surgical, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
402.1 USD
Average target price
423.6 USD
Spread / Average Target
+5.33%
Consensus